Viewing Study NCT04104893


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2026-02-27 @ 10:33 AM
Study NCT ID: NCT04104893
Status: RECRUITING
Last Update Posted: 2025-04-18
First Post: 2019-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
Sponsor: VA Office of Research and Development
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castration Resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic Prostate Cancer View
None Pembrolizumab View
None Checkpoint Inhibitor View
None Mismatch Repair Deficiency View
None CDK12 View